28
Participants
Start Date
August 15, 2024
Primary Completion Date
July 1, 2027
Study Completion Date
July 1, 2028
TACE, Lenvatinib combination with Sintilimab sequential radiotherapy
TACE, Lenvatinib \[8mg(\<60kg)/12mg(\>60kg) orally daily\] combination with Sintilimab (200mg administered intravenous injection on Day 1 of each 21-day cycle) for 2 months. Sequential radiotherapy method and dosage are comprehensively evaluated by radiologists, hepatobiliary surgeons, and oncologists, and discussed by a multidisciplinary team
NOT_YET_RECRUITING
First Affiliated Hospital of Fujian Medical University, Fuzhou
RECRUITING
Fujian Provincial Hospital, Fuzhou
NOT_YET_RECRUITING
Fujian provincial hospital, Fuzhou
NOT_YET_RECRUITING
Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou
Fujian Provincial Hospital
OTHER